Information for clinicians
OmniLenz® is a bandage contact lens (BCL) that allows suture-free transplantation (onlay-barrier application) of Omnigen to the ocular surface in an ambulatory and outpatient setting.
Suture-free transplantation of Omnigen means patients benefit from the barrier function of Omnigen without the need for surgery. Suture-free transplantation of Omnigen is suitable for a range of applications.
OmniLenz® is applied to the surface of the eye in a similar manner to a standard BCL. This means Omnigen can be applied routinely in an outpatient setting where surgery is not available. OmniLenz® application of Omnigen replaces the need for sutures, preventing iatrogenic damage to the compromised ocular surface.
OmniLenz® is derived from a high-water content soft material bandage contact lens base which sits securely on the ocular surface.
The simplicity of application means non-surgical healthcare professionals can be trained to apply OmniLenz® giving patients immediate access to care. OmniLenz should be used in line with the instructions for use.
Outpatient application of Omnigen means more than convenience, it allows unscheduled and emergency suture free intervention to facilitate:
How to apply Omnigen using OmniLenz
OmniLenz® (Onlay-barrier amniotic membrane transplantation) can be considered in a range of settings.
OmniLenz may not be suitable for use in patients who exhibit abnormal blinking, excessive eye rubbing or who are unable to give informed consent.
OmniLenz® allows for the simple application of Omnigen to the surface of the eye in an ambulatory setting. This saves time, resources and cost while ensuring intervention is received as quickly as possible.
Outpatient transplantation of Omnigen has a range of benefits when compared to use of amniotic membrane in a surgical setting and standard of care.
Ambulatory transplantation of Omnigen® using OmniLenz® is considered a human tissue transplantation procedure, therefore use of Omnigen® and OmniLenz® should comply with traceability requirements within your territory.
OmniLenz® is a CE marked product and should be used in line with the instructions for use.
Activity recording involving the application of Omnigen with OmniLenz in the United Kingdom will be based on two NHS OPCS codes: C46.6: Amniotic membrane graft to cornea and C51.5: Placement of therapeutic contact lens on to cornea.
NuVision Biotherapies Ltd
Ocular Healing, naturally
NuVision Biotherapies Ltd
MediCity
D6 Building
Thane Road
Nottingham
NG90 6BH
Opening: 9am-5pm, Mon-Fri
© 2020 NuVision Biotherapies Ltd
All rights reserved
Registered in England & Wales. Company N. | VAT Registration: 222465234
Terms and Conditions | Cookie Policy | Privacy Policy
Website by Clifton Media